The University of Southampton
University of Southampton Institutional Repository

Increased valency of conserved-mosaic vaccines enhances the breadth and depth of epitope recognition

Record type: Article

The biggest roadblock in development of effective vaccines against human immunodeficiency virus type 1 (HIV-1) is the virus genetic diversity. For T-cell vaccine, this can be tackled by focusing the vaccine-elicited T-cells on the highly functionally conserved regions of HIV-1 proteins, mutations in which typically cause a replicative fitness loss, and by computing multivalent mosaic proteins, which maximize the coverage of potential 9-mer T-cell epitopes of the input viral sequences. Our first conserved region vaccines HIVconsv employed clade alternating consensus sequences and showed promise in the initial clinical trials in terms of magnitude and breadth of elicited CD8(+) T-cells. Here, monitoring T-cells restricted by HLA-A*02:01 in transgenic mice, we assessed whether or not the tHIVconsv design (HIVconsv with a tissue plasminogen activator leader sequence) benefits from combining with a complementing conserved mosaic immunogen tHIVcmo, and compared the bivalent immunization to that with trivalent conserved mosaic vaccines. A hierarchy of tHIVconsv ? tHIVconsv+tHIVcmo < tCmo1+tCmo2+tCmo3 vaccinations for induction of CD8(+) T-cell responses was observed in terms of recognition of tested peptide variants. Thus, our HLA-A*02:01-restricted epitope data concur with previously published mouse and macaque observations and suggest that even conserved region vaccines benefit from oligovalent mosaic design.

PDF 2016 Hanke et al.pdf - Version of Record
Restricted to Repository staff only
Download (1MB)

Citation

Abdul-Jawad, Sultan, Ondondo, Beatrice, Van Hateren, Andy, Gardner, Andrew, Elliott, Tim, Korber, Bette and Hanke, Tomáš (2016) Increased valency of conserved-mosaic vaccines enhances the breadth and depth of epitope recognition Molecular Therapy, 24, (2), pp. 375-384. (doi:10.1038/mt.2015.210). (PMID:26581160).

More information

Accepted/In Press date: 9 November 2015
e-pub ahead of print date: 5 January 2016
Published date: 24 February 2016
Organisations: Cancer Sciences

Identifiers

Local EPrints ID: 393773
URI: http://eprints.soton.ac.uk/id/eprint/393773
ISSN: 1525-0016
PURE UUID: f3c600d4-534c-4d11-92a6-04fd37a48a96
ORCID for Tim Elliott: ORCID iD orcid.org/0000-0003-1097-0222

Catalogue record

Date deposited: 04 May 2016 11:28
Last modified: 17 Jul 2017 19:05

Export record

Altmetrics

Contributors

Author: Sultan Abdul-Jawad
Author: Beatrice Ondondo
Author: Andy Van Hateren
Author: Andrew Gardner
Author: Tim Elliott ORCID iD
Author: Bette Korber
Author: Tomáš Hanke

University divisions

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×